GPR162 and Alzheimer disease: The corresponding size of the distribution mode of GABRD+ or GPR162+-carrying pTau217 EVs was significantly smaller in AD vs NAD (Fig. 4d, h, See Additional file 2: Fig. S6 for the pattern of particle size variation).